Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007
By:
Paid access
|Nov 2019References
- Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985; 2:1–8.
- Garratty G. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1989;5:97–106.
- Garratty G. Review: immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs. Immunohematology 1994;10:41–50.
- Garratty G. Review: drug-induced immune hemolytic anemia; the last decade. Immunohematology 2004;20:138–46.
- Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology 2007;23:105–19.
- Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology 2014;30:44–54.
- Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology 2014;30:85–94.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.
- Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009:73–9.
- Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143–50.
- Garratty G. Drug-induced immune hemolytic anemia. Clin Adv Hematol Oncol 2010;8:98–101.
- Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 2012;11:635–42.
- Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm. Transfusion 2007;47: 697–702.
- Madoz P, Muñiz-Diaz E, Martinez C, et al. Fatal immune hemolytic anemia induced by aceclofenac (abstract). Transfusion 1997;37:36S.
- Manor E, Marmor A, Kaufman S, Leiba H. Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test. JAMA 1976;236:2777–8.
- Garratty G, Stuart B, Postoway N, Bueno R. Antibodies to acetaminophen/phenacetin in normal donors, unselected hospital patients, and a patient with intravascular hemolysis, thrombocytopenia, and renal failure (abstract). Transfusion 1980;20:648.
- González CA, Guzmán L, Nocetti G. Drug-dependent antibodies with immune hemolytic anemia in AIDS patients. Immunohematology 2003;19:10–15.
- Bernasconi C, Bedarida G, Pollini G, Sartori S. Study of the mechanism of hemolysis in a case of acquired hemolytic anemia caused by pyramidon (in Italian). Haematologica 1961;46:697–720.
- Gmür J, Wälti M, Neftel KA. Amoxicillin-induced immune hemolysis. Acta Haematol 1985;74:230–3.
- Salama A, Burger M, Mueller-Eckhardt C. Acute immune hemolysis induced by a degradation product of amphotericin B. Blut 1989;58:59–61.
- Thomson S, Williamson D. A case of ampicillin-induced haemolytic anemia. Can J Med Technol 1974;36:228–9.
- Bengtsson U, Ahlstedt S, Aurell M, Kaijser B. Antazoline-induced immune hemolytic anemia, hemoglobinuria, and acute renal failure. Acta Med Scand 1975;198:223–7.
- Hubert D, Habibi B, Krulik M, Debray J. Immunoallergic hemolytic anemia with thrombocytopenia and acute renal failure induced by aspirin (in French). Presse Med 1984;13:2567–9.
- Bird GWG, Wingham J, Babb RG, Bacon P, Wood D. Azapropazone-associated antibodies. Vox Sang 1984;46: 336–7.
- Salama A, Mueller-Eckhardt C, Kissel K, Pralle H, Seeger W. Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol 1984;58:525–31.
- Salama A, Northoff H, Burkhardt H, Mueller-Eckhardt C. Carbimazole-induced immune haemolytic anaemia: role of drug-red blood cell complexes for immunization. Br J Haematol 1988;68:479–82.
- Maloisel F, Kurtz JE, Andres E, Gorodetsky C, Dufour P, Oberling F. Platin salts-induced hemolytic anemia: cisplatin-and the first case of carboplatin-induced hemolysis. Anticancer Drugs 1995;6:324–6.
- Stefanini M, Johnson NL. Positive antihuman globulin test in patients receiving carbromal. Am J Med Sci 1970;259:49–55.
- Salama A, Mueller-Eckhardt C. Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. Br J Haematol 1987;66:263–6.
- Branch DR, Berkowitz LR, Becker RL, et al. Extravascular hemolysis following the administration of cefamandole. Am J Hematol 1985;18:213–19.
- Moake JL, Butler CF, Hewell GM, Cheek J, Spruell MA. Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity. Transfusion 1978;18:369–73.
- Malaponte G, Arcidiacono C, Mazzarino C, et al. Cephalosporin-induced hemolytic anemia in a Sicilian child. Hematology 2000;5:327–34.
- Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. “Immune complex” mediated intravascular hemolysis due to IgM cephalosporin dependent antibody. Transfusion 1987;27:460–3.
- Eckrich RJ, Fox S, Mallory D. Cefotetan-induced immune hemolytic anemia due to the drug-adsorption mechanism. Immunohematology 1994;10:51–4.
- Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32: 269–71.
- Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239–46.
- Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002;21:101–7.
- Davenport RD, Judd WJ, Dake LR. Persistence of cefotetan on red blood cells. Transfusion 2004;44:849–52.
- Toy E, Nesbitt R, Savastano G, Fox S, Araneta M, Hsueh Y. Warm autoantibody following plasma apheresis complicated by acute intravascular hemolysis associated with cefoxitin-dependent antibody resulting in fatality (abstract). Transfusion 1989;29:51S.
- Novaretti MCZ, Sopeleti CR, Dorlhiac-Llacer PE, Chamone DA. Use of gel microcolumn assay for the detection of drug-induced positive direct antiglobulin tests. J Clin Lab Anal 2005;19:219–27.
- Chambers LA, Donovan LM, Kruskall MS. Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991;95:393–6.
- Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion 1999;39:838–44.
- Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176–9.
- Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26:1390–4.
- Malloy CA, Kiss JE, Challapalli M. Cefuroxime-induced immune hemolysis. J Pediatr 2003;143:130–2.
- Manoharan A, Kot T. Cephalexin-induced haemolytic anaemia (letter). Med J Aust 1987;147:202.
- Gralnick HR, Wright LD Jr, McGinniss MH. Coombs’ positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:725–6.
- Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs tests due to cephalothin. N Engl J Med 1967;277: 123–5.
- Gralnick HR, McGinniss M, Elton W, McCurdy P. Hemolytic anemia associated with cephalothin. JAMA 1971;217:1193–7.
- Giro C, Verlicchi G, Baccarani M. Selective erythroblastic aplasia and hemolytic immunopathic type complement anemia in a patient treated with chloramphenicol (in Italian). G Clin Med 1970;51:112–18.
- Muirhead EE, Groves M, Guy R, Halden ER, Bass RK. Acquired hemolytic anemia, exposures to insecticides and positive Coombs’ test dependent on insecticide preparations. Vox Sang 1959;4:277–92.
- Lindberg LG, Norden A. Severe hemolytic reaction to chlorpromazine. Acta Med Scand 1961;170:195–9.
- Logue GL, Boyd AE 3rd, Rosse WF. Chlorpropamide-induced immune hemolytic anemia. N Engl J Med 1970;283:900–4.
- Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto anti-Jka. Transfusion 1984;24:206–9.
- Arndt PA, Garratty G, Brasfield FM, Vemuri SL, Asuncion DJ. Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody. Transfusion 2010;50:302–7.
- MacKay AD, Mehta A. Autoimmune haemolytic anaemia associated with ciprofloxacin. Clin Lab Haematol 1995;17: 97–8.
- Getaz EP, Beckley S, Fitzpatrick J, Dozier A. Cisplatin-induced hemolysis. N Engl J Med 1980;302:334–5.
- Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988;28:493–5.
- Schroeder ML, Taylor M, Anderson C, Albritton WL. Immune hemolysis in an infant with a staphylococcal infection (abstract). International Society of Blood Transfusion, Montreal, Canada 1980.
- Barbolla L, Fernandez MN, Bajo R, Arrieta R, Gilsanz F. Positive Coombs’ test due to synthetic estrogen therapy (bis(p-acetyloxiphenyl-cyclohexilydene)-methane) (in Spanish). Sangre 1974;19:99–104.
- De Vecchi A, Zanella A, Egidi F, Ponticelli C. Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine. Acta Haematol 1985;73:216–18.
- Duran-Suarez JR, Martin-Vega C, Argelagues E, et al. The I antigen as an immune complex receptor in a case of haemolytic anaemia induced by an antihistaminic agent. Br J Haematol 1981;49:153–4.
- Ciucci AG. A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). Rheumatol Rehabil 1979;(Suppl2):116–21.
- Salama A, Göttsche B, Mueller-Eckhardt C. Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77:546–9.
- Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C. Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 1996;95:640–4.
- Ahrens N, Genth R, Kiesewetter H, Salama A. Misdiagnosis in patients with diclofenac-induced hemolysis: new cases and a concise review. Am J Hematol 2006;81:128–31.
- Rosenfeld CS, Winters SJ, Tedrow HE. Diethylstilbestrol-associated hemolytic anemia with a positive direct antiglobulin test result. Am J Med 1989;86:617–8.
- Lay WH. Drug-induced haemolytic reactions due to antibodies against the erythrocyte/dipyrone complex. Vox Sang 1966; 11:601–10.
- Wong KY, Boose GM, Issitt CH. Erythromycin-induced hemolytic anemia. J Pediatr 1981;98:647–9.
- Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000;40:663–8.
- Mayer B, Genth R, Dehner R, Salama A. The first example of a patient with etoricoxib-induced immune hemolytic anemia. Transfusion 2013;53:1033–6.
- Shirey RS, Morton SJ, Lawton KB, Lowell C, Kickler TS, Ness PM. Fenoprofen-induced immune hemolysis: difficulties in diagnosis and complications in compatibility testing. Am J Clin Pathol 1988;89:410–14.
- Munizza M, Kavitsky D, Schainker BA, Poyser A, Peek C, Nance S. Hemolytic anemia associated with injection of fluorescein. Transfusion 1993;33:689–92.
- Sandvei P, Nordhagen R, Michaelsen TE, Wolthuis K. Fluorouracil (5-FU) induced acute immune haemolytic anaemia. Br J Haematol 1987;65:357–9.
- Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139–43.
- Vassal T, Lentzy M, Maury E, Guidet B, Offenstadt G. Severe immunoallergic hemolytic anemia caused by a glafenine metabolite (in French). Presse Med 1991;20:1434–6.
- Orenstein AA, Yakulis V, Eipe J, Costea N. Immune hemolysis due to hydralazine (letter). Ann Intern Med 1977;86:450–1.
- Vila JM, Blum L, Dosik H. Thiazide-induced immune hemolytic anemia. JAMA 1976;236:1723–4.
- Criel AM, Hidajat M, Clarysse A, Verwilghen RL. Drug dependent red cell antibodies and intravascular haemolysis occurring in patients treated with 9-hydroxy-methyl-ellipticinium. Br J Haematol 1980;46:549–56.
- Martinengo M, Ardenghi DF, Tripodi G, Reali G. The first case of drug-induced immune hemolytic anemia due to hydrocortisone. Transfusion 2008;48:1925–9.
- Korsager S. Haemolysis complicating ibuprofen treatment. Br Med J 1978;1:79.
- Novaretti MCZ, Fonseca GHH, Conchon M, Dorlhiac-Llacer PE, Chamone DAF. First case of immune-mediated haemolytic anaemia associated to imatinib mesylate. Eur J Haematol 2003;71:455–8.
- Faulk WP, Tomsovic EJ, Fudenberg HH. Insulin resistance in juvenile diabetes mellitus. Am J Med 1970;49:133–9.
- Mayer B, Leo A, Herziger A, Houben P, Schemmer P, Salama A. Intravascular immune hemolysis caused by the contrast medium iomeprol. Transfusion 2013;53:2141–4.
- Robinson MG, Foadi A. Hemolytic anemia with positive Coombs’ test. Association with isoniazid therapy. JAMA 1969; 208:656–8.
- Oh YR, Carr-Lopez SM, Probasco JM, Crawley PG. Levofloxacin-induced autoimmune hemolytic anemia. Ann Pharmacother 2003;37:1010–13.
- Arndt PA, Garratty G, Maranto LS, Wohl H. Immune hemolytic anemia associated with mefloquine (letter). Transfusion 1997; 37:1220–1.
- Eyster ME. Melphalan (Alkeran) erythrocyte agglutinin and hemolytic anemia. Ann Intern Med 1967;66:573–7.
- Pujol M, Fernández F, Sancho JM, Ribera JM, Millá F, Feliu E. Immune hemolytic anemia induced by 6-mercaptopurine. Transfusion 2000;40:75–6.
- Sivamurthy S, Frankfurt E, Levine ME. Positive antiglobulin tests in patients maintained on methadone. Transfusion 1973; 13:418–21.
- Woolley PV 3rd, Sacher RA, Priego VM, Schanfield MS, Bonnem EM. Methotrexate-induced immune haemolytic anaemia. Br J Haematol 1983;54:543–52.
- Nordhagen R, Vik H, Wolthuis K, Bohn HP, Urdahl P, Michaelsen TE. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium. Transfusion 1991;31:843–6.
- Kudoh T, Nagata N, Suzuki N, Nakata S, Chiba S, Takahashi T. Minocycline-induced hemolytic anemia. Acta Paediatr Jpn 1994;36:701–4.
- Johnson ST, Bandouveres S, Aster RH, Bougie D. Nabumetone metabolite-dependent antibody reacting with untreated red cells in the presence of urinary metabolite (abstract). Transfusion 2003;43:101A.
- Kroovand S, Kirtland HH, Issitt CH. A positive direct antiglobulin test due to sodium nafcillin (abstract). Transfusion 1977;17:682.
- Lo TZH, Martin MA. Autoimmune haemolytic anaemia associated with naproxen suppositories. BMJ 1986;292:1430.
- Duran-Suarez JR, Martin-Vega C, Argelagues E, Massuet L, Ribera A, Triginer J. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41:313–15.
- Bournerias F, Nabibi B. Nomifensine-induced immune haemolytic anaemia and impaired renal function (letter). Lancet 1979;2:95–6.
- Abad A, López P, Bauza J. Norfloxacin-induced positive direct antiglobulin test (letter). Vox Sang 1999;77:238.
- Desrame J, Broustet H, Darodes de Tailly P, Girard D, Saissy JM. Oxaliplatin-induced haemolytic anaemia. Lancet 1999;354:1179–80.
- Arndt PA, Garratty G, Isaak E, Bolger M, Lu Q. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Transfusion 2009;49:711–18.
- MacGibbon BH, Loughridge LW, Hourihane DO, Boyd DW. Autoimmune haemolytic anaemia with acute renal failure due to phenacetin and p-aminosalicylic acid. Lancet 1960;1:7–10.
- Park GM, Han KS, Chang YH, Kim CH, Lee JC. Immune hemolytic anemia after treatment with pemetrexed for lung cancer (letter). J Thorac Oncol 2008;3:196–7.
- Strumia PV, Raymond FD. Acquired hemolytic anemia and antipenicillin antibody. Case report and review of literature. Arch Intern Med 1962;109:603–8.
- Petz LD, Fudenberg HH. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med 1966; 274:171–8.
- Muirhead EE, Halden ER, Groves M. Drug-dependent Coombs (antiglobulin) test and anemia; observations on quinine and acetophenetidin (phenacetin). Arch Intern Med 1958;101: 87–96.
- Johnson ST, Weitekamp LA, Sauer DE, Fueger JT, Aster RH. Piperacillin-dependent antibody with relative e specificity reacting with drug treated red cells and untreated red cells in the presence of drug (abstract). Transfusion 1994;34:70S.
- Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Immune hemolytic anemia associated with probenecid. Am J Clin Pathol 1985;84:391–4.
- Rubio-Martínez A, García-Erce JA, Salvador C, Gómez-Arteta E, Gimeno JJ. Autoimmune haemolytic anaemia induced by propyphenazone (letter). Vox Sang 1998;75:257.
- Chen F, Liu S, Wu J. Puerarin-induced immune hemolytic anemia. Int J Hematol 2013;98:112–13.
- Freedman AL, Barr PS, Brody EA. Hemolytic anemia due to quinidine: observations on its mechanism. Am J Med 1956; 20:806–16.
- Pixley JS, MacKintosh FR, Sahr EA, Zanjani ED. Mechanism of ranitidine associated anemia. Am J Med Sci 1989;297: 369–71.
- Blajchman MA, Lowry RC, Pettit JE, Stradling P. Rifampicin-induced immune thrombocytopenia. Br Med J 1970;3:24–6.
- Worlledge S. Hong Kong Treatment Services–Royal Postgraduate Medical School–British Medical Research Council Co-operative Study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies. Scand J Respir Dis 1973;84:60–3.
- Worlledge S. Hong Kong Treatment Services–Royal Post-graduate Medical School–British Medical Research Council Co-operative Study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data. Scand J Respir Dis 1973;84:125–8.
- Harris JW. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med 1956;47:760–75.
- Mathiesen O, Grunnet N. Haemolysis after intravenous streptokinase (letter). Lancet 1989;1:1016–17.
- Letona JM, Barbolla L, Frieyro E, Bouza E, Gilsanz F, Fernández MN. Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561–71.
- Florendo NT, MacFarland D, Painter M, Muirhead EE. Streptomycin-specific antibody coincident with a developing warm autoantibody. Transfusion 1980;20:662–8.
- Fernández MN, Barbolla L. Streptomycin-specific antibodies (letter). Transfusion 1982;22:344–5.
- Teplitsky V, Virag I, Halabe A. Immune complex haemolytic anaemia associated with sulfasalazine. BMJ 2000;320:1113.
- Johnson FP Jr, Hamilton HE, Liesch MR. Immune hemolytic anemia associated with sulindac. Arch Intern Med 1985;145:1515–16.
- van Dijk BA, Rico PB, Hoitsma A, Kunst VA. Immune hemolytic anemia associated with tolmetin and suprofen. Transfusion 1989;29:638–41.
- Law IP, Wickman CJ, Harrison BR. Coombs’-positive hemolytic anemia and ibuprofen. South Med J 1979;72: 707–10.
- Coluccio E, Villa MA, Villa E, et al. Immune hemolytic anemia associated with teicoplanin. Transfusion 2004;44:73–6.
- Maguire RB, Stroncek DF, Gale E, Yearlsey M. Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am J Hematol 1994;46:363–6.
- Habibi B, Lopez M, Serdaru M, et al. Immune hemolytic anemia and renal failure due to teniposide. N Engl J Med 1982;306:1091–3.
- Wenz B, Klein RL, Lalezari P. Tetracycline-induced immune hemolytic anemia. Transfusion 1974;14:265–9.
- Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. Specific involvement of red-cell antigen I. N Engl J Med 1985;312: 353–5.
- Arndt PA, Wolf CF, Kripas CJ, Garratty G. First example of an antibody to ticarcillin: a possible cause of hemolytic anemia (abstract). Transfusion 1999;39:47S.
- Bird GW, Eeles GH, Litchfield JA, Rahman M, Wingham J. Haemolytic anaemia associated with antibodies to tolbutamide and phenacetin. Br Med J 1972;1:728–9.
- Leitman SF, Lee BJ, McGinniss MH, Shulman NR, Frank MM. Massive immune hemolysis, disseminated intravascular coagulation (DIC), and acute renal failure in association with tolmetin ingestion (abstract). Transfusion 1984;24:426.
- Takahashi H, Tsukada T. Triamterene-induced immune haemolytic anaemia with acute intravascular haemolysis and acute renal failure. Scand J Haematol 1979;23:169–76.
- Ahmad D, Morgan WK, Patterson R, Williams T, Zeiss CR. Pulmonary haemorrhage and haemolytic anaemia due to trimellitic anhydride. Lancet 1979;2:328–30.
- Ermis B, Caner I, Karacan M, Olgun H. Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use (letter). Thromb Haemost 2003;90:158–9.
- Betensky M, Fisher MJ, Nance SJ, Weiss M, Witmer C, Sesok-Pizzini D. Carboplatin and vincristine induced hemolytic anemia in a pediatric patient with an optic pathway glioma (abstract). Transfusion 2013;(53Suppl):32A.
- Schulenburg BJ, Beck ML, Pierce SR, Plapp FV, Cooper DG. Immune hemolysis associated with ZomaxTM (abstract). Transfusion 1983;23:409.
- Elimelakh M, Dayton V, Park KS, et al. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenalate, and daclizumab in pancreas transplant recipients. Haematologica 2007;92: 1029–36.
- Goldschmidt N, Gural A, Ben-Yehuda D, Gatt ME. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia. Cancer Chemother Pharmacol 2013;72:709–13.
- Luderer JR, Schoolwerth AC, Sinicrope RA, Ballard JO, Lookingbill DP, Hayes AH Jr. Acute renal failure, hemolytic anemia and skin rash associated with captopril therapy. Am J Med 1981;71:493–6.
- Tregellas WM, South SF. Autoimmune syndrome induced by chaparral ingestion (abstract). Transfusion 1980;20:647–8.
- Rotoli B, Formisano S, Alfinito F. Autoimmune haemolytic anaemia associated with cimetidine (letter). Lancet 1979;2:583.
- Fleischman RA, Croy D. Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia (letter). Am J Hematol 1995; 48:293.
- Nussey AM. Fenfluramine and haemolytic anaemia (letter). Br Med J 1973;1:177–8.
- Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia (letter). Ann Oncol 1992;3:171–2.
- Di Raimondo F, Giustolisi R, Cacciola E, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 1993;11:63–8.
- Akard LP, Hoffman R, Elias L, Saiers JH. Alpha-interferon and immune hemolytic anemia (letter). Ann Intern Med 1986; 105:306–7.
- Perez R, Padavic K, Krigel R, Weiner L. Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon. Cancer 1991;67:2512–17.
- Umstead GS, Babiak LM, Tejwani S. Immune hemolytic anemia associated with ketoconazole therapy. Clin Pharm 1987;6:499–500.
- Darabi K, Kantamnei S, Wiernik PH. Lenalidomide-induced warm autoimmune hemolytic anemia. J Clin Oncol 2006; 24:e59.
- Cotzias GC, Papavasiliou PS. Autoimmunity in patients treated with levodopa (letter). JAMA 1969;207:1353–4.
- Scott GL, Myles AB, Bacon PA. Autoimmune haemolytic anaemia and mefenamic acid therapy. Br Med J 1968;3:534–5.
- Snapper I, Marks D, Schwartz L, Hollander L. Hemolytic anemia secondary to mesantoin. Ann Intern Med 1953;39: 619–23.
- Carstairs K, Worlledge S, Dollery CT, Breckenridge A. Methyldopa and haemolytic anaemia (letter). Lancet 1966; 1:201.
- Gilbertson C, Jones DR. Haemolytic anaemia with nalidixic acid (letter). Br Med J 1972;4:493.
- Jones GW, George TL, Bradley RD. Procainamide-induced hemolytic anemia. Transfusion 1978;18:224–7.
- Kleinman S, Nelson R, Smith L, Goldfinger D. Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide. N Engl J Med 1984;311:809–12.
- Jourdan E, Topart D, Richard B, Jourdan J, Sotto A. Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder. Leuk Lymphoma 2003;44:889–90.
- DiGiuseppe JA, Bastacky SI, Shirey RS, Silberman MA, Hutchins GM, Ness PM. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. Arch Pathol Lab Med 1996;120:282–5.
- Shen Y. Autoimmune hemolytic anemia associated with a formulation of traditional Chinese medicines. Am J HealthSyst Pharm 2009;66:1701–3.
- Williams ME, Thomas D, Harman CP, Mintz PD, Donowitz GR. Positive direct antiglobulin tests due to clavulanic acid. Antimicrob Agents Chemother 1985;27:125–7.
- Garratty G, Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998;100:777–83.
- Smith RL, Gralnick MA, Cysyk RL, Gralnick HR. Red cell alterations by a new chemotherapeutic agent (abstract). Transfusion 1974;14:513.
- Jamin D, Demers J, Shulman I, Lam HT, Momparler R. An explanation for nonimmunologic adsorption of proteins onto red blood cells: Schiff’s base reactions. Blood 1986;67:993–6.
- Lutz P, Dzik W. Very high incidence of a positive direct antiglobulin test (+DAT) in patients receiving Unasyn (abstract). Transfusion 1992;32:23S.
- Jamin D, Shulman I, Lam HT, et al. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med 1988;112:898–900.
- Broadberry RE, Farren TW, Bevin SV, et al. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG on patient’s red cells. Transfus Med 2004;14:53–7.
- Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells (letter). Vox Sang 2003;85:53.
- Salama A, Mayer B. Diagnostic pitfalls of drug-induced hemolytic anemia. Immunohematology 2014;30:80–84.
- Habibi B, Bretagne Y. Blood group antigens may be the receptors for specific drug-antibody complexes reacting with red blood cells (in French). CR Seances Acad Sc III 1983;296:693–6.
- Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68:1285–8.
- Arndt PA, Revilla J, Leger RM, Garratty G. Studies on specificity of selected drug-dependent antibodies (abstract). Transfusion 2013;(53Suppl):17A.
- Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion 2008;48:2429–34.
- Leger RM, Garratty G. Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors. Transfusion 2011;51:1740–4.
- Arndt PA, Leger RM, Garratty G. IgM agglutinins to meropenem, a beta-lactam antibiotic, are found in plasma of healthy blood donors and random patients (abstract). Transfusion 2012;(52Suppl):26A.
- Hamblin TJ, Orchard JA, Myint H, Oscier DG. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia. J Clin Oncol 1998;16:3209–10.
- Myint H, Copplestone JA, Orchard J, et al. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995;91:341–4.
- Gonzalez H, Leblond V, Azar N, et al. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Hematol Cell Ther 1998;40:113–18.
- Dearden C, Wade R, Else M, et al.; UK National Cancer Research Institute (NCRI); Haematological Oncology Clinical Studies Group; NCRI CLL Working Group. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood 2008;111:1820–6.
- Hamblin TJ. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 2006;33:230–9.
- Borthakur G, O’Brien S, Wierda WG, et al. Immune anaemias in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide and rituximab—incidence and predictors. Br J Haematol 2007;136:800–5.
- Glance LE, Cumpston A, Kanate A, Remick SC. Bendamustine-associated hemolytic anemia. Ann Pharmacol 2009;43: 1903–6.
DOI: https://doi.org/10.21307/immunohematology-2019-100 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 66 - 79
Published on: Nov 6, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2019 G. Garratty, P.A. Arndt, published by American National Red Cross
This work is licensed under the Creative Commons License.